COMP <GO>
HR vs JPM // GROSS PROFIT MARGIN
Healthcare Realty Trust Incorporated (NYSE) VS. JPMorgan Chase & Co. (NYSE) • 15-METRIC TALLY: HR 7
— JPM 6
■ METRIC PARITY
LAST: $18.49 (+1.99%) • MKT CAP: $6.21B
gross-margins
41.00%
LAST: $337.04 (-1.90%) • MKT CAP: $895.92B
gross-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HR VS. JPM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HR | JPM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 41.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -3.70% | 17.37% | -21.07 | JPM | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 9.7x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 7.34% | -18.14% | +25.48 | HR | /fcf-yield <GO> |
| Operating Margin | -60.00% | 42.07% | -102.07 | JPM | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 32.63% | -92.63 | JPM | /net-margins <GO> |
| Revenue Growth (YoY) | 47.30% | 13.53% | +33.77 | HR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 6.23% | 1.96% | +4.27 | HR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.25 | 0.37 | +0.88 | HR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 2/9 | +6.00 | HR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 4.84% | +2.16 | JPM | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.2 | 49.0 | +11.11 | HR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 1.00 | +0.02 | HR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 34.0x | 13.6x | +20.43 | JPM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.21B | $895.92B | -$889.70B | JPM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HR REV | JPM REV | HR GROSS % | JPM GROSS % | HR FCF | JPM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $28.2M | $182.45B | 44.0% | — | $455.8M | -$147.78B |
| FY 2024 | $19.2M | $177.56B | 44.0% | — | $500.8M | -$42.01B |
| FY 2023 | $17.5M | $158.10B | 44.0% | — | $499.0M | $12.97B |
| FY 2022 | — | $128.69B | — | — | — | $107.12B |
| FY 2021 | — | $121.65B | — | — | — | $78.08B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HR // BETA 1.02
JPM // BETA 1.00